The Recall Desk
Severity pendingFDA (Drugs)·D-0220-2026·Announced 2025-12-17

GANIRELIX ACETATE (GANIRELIX ACETATE)

Pending LLM rewrite. Source: FDA_DRUG D-0220-2026.

Severity not yet assessed

We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.

Plain-English summary

Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

The recalled product

Product
GANIRELIX ACETATE (GANIRELIX ACETATE)
Brand
GANIRELIX ACETATE
Manufacturer
Lupin Pharmaceuticals Inc.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: WB00006
  • Exp 12/31/2026

UPCs (1)

  • 0370748274019

Distribution

Distributed in 4 states:

  • FL
  • MA
  • MI
  • OH